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Abstract
Objective
Americans do not vaccinate nearly enough against Influenza (flu) infection, despite severe
health and economic burden of influenza. Younger people are disproportionately responsi-
ble for transmission, but do not suffer severely from the flu. Thus, to achieve herd immunity,
prosocial motivation needs to be a partial driver of vaccination decisions. Past research has
not established the causal role of prosociality in flu vaccination, and the current research
evaluates such causal relationship by experimentally eliciting prosociality through mes-
sages about flu victims.
Methods
In an experimental study, we described potential flu victims who would suffer from the deci-
sion of others to not vaccinate to 3952 Internet participants across eight countries. We mea-
sured sympathy, general prosociality, and vaccination intentions. The study included two
identifiable victim conditions (one with an elderly victim and another with a young victim), an
unidentified victim condition, and a no message condition.
Results
We found that any of the three messages increased flu vaccination intentions. Moreover,
this effect was mediated by enhanced prosocial motives, and was stronger among people
who were historical non-vaccinators. In addition, younger victim elicited greater sympathy,
and describing identifiable victims increased general sympathy and prosocial motives.
Conclusions
These findings provide direct experimental evidence on the causal role of prosocial motives
in flu vaccination, by showing that people can be prompted to vaccinate for the sake of
benefiting others.
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Introduction
Imagine Walter, who was 76 years old and was not able to get the flu vaccine last year due to
mobility issues. Walter relied on other people to get vaccinated to reduce the chance that they
spread the virus to him. Last year, many people neglected to get the Influenza (flu) vaccine, and
Walter became infected. As a result of his infection, he acquired pneumonia. He was in a criti-
cal condition for several weeks before passing away.
Flu infection leads to about 200,000 hospitalizations [1], 610,660 life-years lost, and $87.1
billion financial cost [2] in the U.S. each year. Although flu vaccination is the most effective
way to prevent the flu, Americans do not vaccinate even close to the 70% rate set by the 2020
Healthy People initiative [3]. The story about Walter highlights the societal effect of vaccina-
tion: Flu vaccination reduces the risk of onward transmission to others in addition to reducing
the risk of infection for oneself, a phenomenon known as herd immunity [4]. This “herd
immunity” entails that flu vaccination is a prosocial behavior.
Prosocial behavior is defined as behavior that benefits others, whether or not it involves an
overall cost to self [5]. Prosocial behavior has received extensive attention in psychological
research, as it includes a variety of important social behaviors such as helping, sharing, cooper-
ation, and charitable donation etc [6, 7]. Flu vaccination benefits other people through herd
immunity. Thus, we use the term “prosociality” in this paper to discuss the motivation in flu
vaccination that is intended to help others.
Prosocial motivation is especially critical in flu vaccination because flu transmission and
morbidity is asymmetric: Young people are responsible for the majority of transmission [8],
but in a typical year, 90% of flu-related deaths happen to those above 65 years of age [9]. Thus,
the most efficient way to reduce the societal disease burden of flu is for the majority of young
people below 65 years old to vaccinate and bear the cost of doing so (fee, inconvenience, and
perceived side effects), even though they experience less personal benefit from vaccination[10].
That is, prosocial motivations, or the concern to benefit others, need to affect flu vaccination to
achieve the optimal vaccine coverage[10]. In this paper, we ask whether prosocial motives do
in fact lead people to vaccinate against the flu.
Past research on prosocial motivation and vaccination
Existing research suggests that prosocial motives do play a role in vaccination decisions. For
instance, in scenarios about hypothetical vaccines, study participants were more likely to
receive the vaccine when they learned that their vaccination can benefit more people, [11, 12],
when the social benefit of vaccination was emphasized and cost of vaccination was low [13], or
when they were incentivized to care about others in a simulated flu game [14]. Shim et al. [15]
also found a positive association between concerns for spreading the flu to others and the deci-
sion to vaccinate, even after controlling for self-interested concern about contracting the flu.
These findings are limited, however, either by the hypothetical nature of the vaccine in the sce-
narios, or by the correlational design of the study.
In parallel, research on parental vaccination decisions also indicates that “there may be a
general willingness to immunize children for the benefit of others” [16], but the evidence
comes largely from interviews or questionnaires directly asking parents their reasons to vacci-
nate. In contrast, a recent experimental study found that emphasizing societal benefit did not
increase parents’ intentions to vaccinate their child with the MMR vaccine without mentioning
benefits to the child [17]. Thus, the existing evidence does not provide conclusive support for
the causal impact of prosocial motives on vaccination decisions.
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The current study
The goal of the current study was to provide a stringent test of whether prosocial motives have a
direct causal impact on vaccination decisions in the context of flu vaccination. We aimed to
experimentally elicit prosocial motivation using messages, and in turn, to promote flu vaccina-
tion. How can we effectively activate prosocial motivation in flu vaccination? Past research on
the reason for prosocial behavior has demonstrated that greater empathy [18] and a heightened
sense of personal responsibility [19] towards the victim are powerful motivating factors in proso-
cial behavior. We drew on this research to create several messages: To increase empathy and per-
sonal responsibility, we described the negative consequences that flu victims might suffer, and
emphasized the personal responsibility of those who failed to vaccinate for such consequences.
We used an experimental design to clearly delineate the causal role of prosociality. The
experiment included a control condition where no message about flu vaccination was pre-
sented, and three experimental conditions were different versions of prosocial messages were
presented. As outcome variables, we measured participants’ prosocial motivation and inten-
tions to receive a flu vaccine. Because participants were randomly assigned to different condi-
tions, all other factors that can contribute to flu vaccination, such as preexisting attitudes about
the vaccine, risk perceptions, perceived social norm etc. [20, 21], are equated across conditions,
leaving the experimental manipulation the unambiguous cause of any potential difference in
the outcome variables. To our knowledge, this is the first experimental study directly testing
the causal role of prosocial motivation in flu vaccination.
Among the three versions of the prosocial messages, we also tested whether description of
identifiable victims may be more effective in eliciting prosocial motives than description of
unidentified victims. This research question was informed by past research on charitable giv-
ing, which shows that describing a victim with identifying details (e.g., name, age, picture,
short story) elicits a powerful emotional response [22], and generates more charitable giving
compared to similar descriptions of unidentified victims [23–26]. We designed two messages
that described a flu victim (one using a young victim, and another using an old victim) with
name, age, picture, and a short story, and compared them with another message that described
flu victims in general without these identifying details (see Methods).
As part of a larger survey about international views on vaccination [27], this study was con-
ducted among an Internet panel across 8 countries.
Materials and Methods
Data collection
We requested 500 completed Internet survey responses per country from 8 countries through
the commercial survey company Research Now (RN). RN recruited 4023 participants before
the start of each country’s flu season from China (N = 499), France (N = 497), Japan (N = 501),
United Kingdom (N = 496) and United States (N = 473) during September 13–23, 2013, Israel
(N = 500) during October 1–5, 2013 (to avoid a major Israeli holiday), and Brazil (N = 490)
and South Africa (N = 496) during March 10–18, 2013. Participants were recruited either from
the RN or affiliate panelist pools. We excluded 63 respondents whose IP address conflicted
with their country of residence in the RN database, 6 respondents who were younger than 18
years old, and 2 responses from participants who took the survey a second time, yielding 3952
final responses. The response rates in each country ranged from 2% (China) to 20% (Japan),
with a median of 10.5%.
We set quotas within each country where feasible to achieve a representative sample across
age and gender (See Table 1). We aimed to achieve an equal balance of male and female
Prosocial Vaccination
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participants for greater representativeness of the actual population. All countries except Israel
and South Africa (which had limited Internet participants) had a gender quota of 50% male
and 50% female. Because of younger people tend to be over represented among Internet users,
we also set age quotas to ensure a decent representation of older participants. For France,
Japan, United Kingdom and United States, we specified 20% participants should be 50 years or
older; in Brazil we adjusted this quota to 10%, and in China we specified that 30% of partici-
pants should be 35 years or older. We set no age quota in Israel due to limitations in the size of
the participant pool available.
The study was part of a larger survey about seasonal flu and flu vaccination [28], which
included questions about participants’ flu vaccination history, contact patterns, how people
influence each others’ vaccination decisions, as well as hypothetical scenarios about flu vaccina-
tion. All study materials were translated into the official language of the respective countries
(Portuguese, Chinese, French, Hebrew, Japanese, British English, and American English) and
back translated to ensure accuracy. We initiated the survey in the primary language of the par-
ticipant’s location, but participants could also select any of the 7 languages above.
We obtained IRB approval at Rutgers University (IRB protocol 12–782), Yale University
(IRB protocol 120710537) and University of Colorado Denver (IRB protocol 12–1212). All par-
ticipants read the consent form (translated into appropriate language) before participating in
the study, and assented to the study by clicking a button to proceed to the next page of the sur-
vey. The consent procedure was approved by the IRB, and recorded as part of the dataset.
Questionnaire
The current study was positioned at the end of the larger survey. Participants were randomly
assigned to one of four conditions: They either read a message about flu vaccination that
involved an identified young victim, an identified elderly victim, a general message about
unidentifiable flu victims, or no message. We included the elderly victim condition because
they are the usual victims of severe flu-related illnesses, and included the young victim condi-
tion because children under 6-months of age are not eligible for the flu vaccine [9], and thus,
rely solely on the vaccination of people around them for protection. Another reason for includ-
ing the young victim condition was to see whether young victims could elicit greater prosocial
motives, as past research has shown that people value lives of younger people more than older
people [29–31].
In the two identifiable victim conditions (young victim or elderly victim), participants were
informed: “The persons described in the following scenario are fictional but their stories are
based on true events.” The elderly victim scenario described a 76-year old man who contracted
flu and eventually died last year because others had neglected to vaccinate; the young victim
Table 1. Participant Age and Gender Distribution by Country.
Country n M SD Med Min Max % 35 years or older % 50 years or older % of female
Brazil 490 35.44 11.13 35 18 77 50.4 9.8 51
China 499 33.13 9.81 31 19 89 29.7 6.8 50
France 497 40.02 12.97 38 18 77 59.6 20.1 50
Israel 500 38.77 15.01 33 18 98 46.6 28.8 58
Japan 501 39.90 13.53 37 18 100 57.9 20.0 50
SA 496 37.60 12.18 35 18 74 52.8 17.5 60
UK 496 40.66 12.80 40 18 80 63.5 20.2 50
US 473 40.49 12.53 38 19 82 60.5 20.1 49
doi:10.1371/journal.pone.0159780.t001
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scenario described a 5-month old boy. Both messages included name and photo of a smiling
victim, varied by country, and age of victim [24–26]. The unidentified victim message
described how neglecting to vaccinate can cause the flu to spread to others, who might die of
complications, and included an image of a smiling a doctor to equalize the three message con-
ditions. In the no message condition, no such scenarios were presented. We used images of
white victims in European and American countries (France, Israel, UK, US, and Brazil), images
of Asian victims in China and Japan, and images of black victims in South Africa. All images
portrayed male victims, to avoid the cofounding effect of victim gender across countries. See S1
Supporting Information for original messages. The images are not presented in the paper for
confidentiality reasons.
The name of the younger and older character as well as the appearance of the person in the
images were adapted to represent the majority population in the European/American countries
(France, Israel, UK, and US), Asian countries (China and Japan), and African Country and
(South Africa), respectively. Participants in the three message conditions also answered two
comprehension questions about the message, and re-read the message again if they answered
either question incorrectly.
We measured three variables: sympathy, general prosociality, and vaccination intentions
(see S1 Supporting Information). We asked participants how much sympathy they felt for the
flu victim who died (elderly & young victim conditions) or victims who may have died (general
condition). Prosocial motive was measured as the likelihood that the participant would donate
money to the Against Malaria Foundation. (We also asked how much they would be willing to
donate, but did not analyze the amount due to the complication of different currencies and
wages across countries). To determine vaccination intention, we asked whether participants
had already received the flu vaccine this year, and if not, how likely they were to get the flu vac-
cine this coming flu season. We reminded participants to be objective and consider not only
the potential benefits of vaccination, but also any reservations they may have and practicalities
involved, such as making the appointment and going to the clinic. Sympathy was measured on
a seven-point scale from 1 “very little” to 7 “very much”, and likelihood to donate and vaccinate
were both measured on a scale from 0% to 100%, in 10% increments. We measured these vari-
ables in all four conditions, except sympathy, which we only asked in the three message condi-
tions, where victims were involved. We randomly assigned the order of the sympathy and
general prosociality measures, and asked likelihood to vaccinate question last.
Summary of analysis approach
To analyze the effect of message conditions on sympathy, prosociality, and vaccination
intentions, we used Analysis of Variance (ANOVA) to test the overall difference of each out-
come variable across 4 conditions (except for sympathy, only 3 conditions were available), as
well as focused contrasts to test whether the three conditions containing message differed
from the no-message condition, whether the two identified message conditions differed from
the general message condition, and whether the young victim condition differed from the
old victim condition. Where homogeneity of variance was not met, Welch test was reported.
Similar analyses accounting for country, age, and gender as covariance were conducted using
Analysis of Covariance (ANOCOVA), with details described in S2 Supporting Information.
We also performed meditational analyses with sympathy as a potential mediator for the
effect of identifiable victim on prosociality, and with prosociality as a potential mediator for
the effect of message (vs. no message) on vaccination intentions, both using the PROCESS
macro developed by Hayes [32], which is based on bootstrapping estimation of the indirect
effect.
Prosocial Vaccination
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In the analyses on vaccination intentions, we also performed analyses among all partici-
pants, as well as among participants who did versus did not receive flu vaccine in the prior year
separately.
Results
Sympathy
All participants who read one of the three messages (N = 2968) reported sympathy towards the
victim(s) of flu. A one-way ANOVA showed a significant overall effect of condition, Welch’s
test (accounting for heterogeneity of variance) = 58.64, p< .001. Focused contrasts showed
that the young victim message (M = 6.05, 95% CI [5.96, 6.14]) elicited greater sympathy than
the old victim message (M = 5.56, 95% CI [5.46, 5.65]), t (1979.32) = 7.34, Cohen’s D = 0.33,
r = .16, p< .001, and these two identifiable victim conditions pooled elicited greater sympathy
than the general information condition (M = 5.32, 95% CI [5.22, 5.42]), t (1814.51) = 7.80,
Cohen’s D = 0.37, r = .18, p< .001.
Prosocial motives
Among all 3952 valid participants, a one-way ANOVA revealed a significant effect of message
condition on prosocial motivation, as measured in likelihood to donate to an irrelevant cause,
Welch’s test = 12.82, p< .001 (Fig 1). The three message conditions pooled elicited greater like-
lihood to donate compared to the no-message condition, t (1774.57) = 5.02, Cohen’s D = 0.24,
r = .12, p< .001; similarly, the two identifiable victim conditions led to greater donation
Fig 1. Mean Prosocial Motives as Measured in Rated Likelihood to Donate to an Unrelated Cause. Error
Bars: ± 2SEs (95% CI).
doi:10.1371/journal.pone.0159780.g001
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intentions compared to the general message condition, t (1966.53) = 3.41, Cohen’s D = 0.15,
r = .08, p = .001. Young and old victim conditions led to similar likelihood to donate, p> .20.
As we expect sympathy to be a motivator of prosociality, we assessed the mediating role of
sympathy in the effect of message on donation intentions. Given that sympathy was only
assessed in the three message conditions, we were specifically interested in the role of sympathy
in the elevated donation intentions among the identifiable victim messages compared to the
general message. We conducted a mediation analysis using the contrast between the identifi-
able victim conditions and the unidentifiable victim condition as the predictor, donation inten-
tions as the outcome variable, and sympathy as the mediator. We used the PROCESS Macro
developed for SPSS by Hayes [32] to estimate the mediation effect, with a bias-corrected boot-
strapping method and 5000 resampling (Fig 2). Sympathy significantly mediated the impact of
the identifiable victim on prosociality, indirect effect B = 0.024, 95% CI [0.018, 0.031], which
represents a small effect, κ2 = .039, 95% CI [0.029, 0.050]. This means that compared to the
general message, the identifiable victim messages led to a 2.4% (0.024) absolute increase (on a
percentage likelihood scale) in prosociality in response to identifiable victim messages because
of heightened sympathy. Thus confirming the role of sympathy in prosocial messaging.
Vaccination intentions
We analyzed vaccination intentions for 3518 participants who reported not to have received a
flu vaccine for the upcoming season, and thus answered the vaccination intention question.
In a one-way ANOVA, vaccination intentions differed across the four conditions, F (3,
3514) = 5.40, partial η2 = .005. Focused contrast showed that the three message conditions pro-
duced significantly higher intentions to vaccinate than the no-message condition,MMessage =
44%, 95% CI [42%, 45%] vs.MNo-message = 38%, 95% CI [36%, 41%], t (3514) = 3.98, Cohen’s
D = 0.13, r = .07, p< .01. This 6-percentage point absolute increase represents a 15% relative
increase in the reported desire to receive a vaccine. Neither the contrast between the identifi-
able victim conditions and general information condition, nor the contrast between young and
old victim conditions was significant (p> .57 for both).
Our data also confirmed a previous finding that one major predictor for flu vaccination of a
given individual is prior vaccination behavior [20]: As shown in Fig 3, participants who had
vaccinated in the prior year (n = 909) indicated a 77% likelihood to vaccinate this year on aver-
age, 95% CI [75%, 79%], with close to half of these participants (n = 418) indicating a 100%
Fig 2. Mediational Model for the effect of identifiable victim on prosocial motives, mediated by sympathy. This
mediation was based on the bootstrapping method for calculating indirect effect. Analysis was performed in SPSS using the
PROCESSmacro developed by Hayes [32], with 5000 resampling to compute the Bias Corrected boot strapped 95%
Confidence Intervals (BCa CI). Total effect of identifiable victim on prosocial motive was significant, B = 0.039, BCa 95%CI
[0.017, 0.061], p = .007.
doi:10.1371/journal.pone.0159780.g002
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likelihood; conversely, participants who had not vaccinated in the prior year (n = 2530) indi-
cated a much lower mean likelihood to vaccinate: 29%, 95% CI [28%, 31%], and only 4%
(n = 93) of these participants indicated a 100% likelihood. Thus, the latter group is in particular
need of interventions to encourage their vaccination.
We tested the effect of message for these two groups separately. Among those who had vac-
cinated in the previous year, vaccination intention did not vary significantly across conditions,
either in omnibus test or contrast tests. This group of people was uniformly highly likely to
vaccinate this year. But for participants who had not vaccinated in the previous year, the over-
all effect of message condition was significant, Welch’s test = 11.10, p< .001. Among these
historical non-vaccinators, the contrast between the message conditions and the no-message
was significant,MMessage = 31%, 95% CI [30%, 33%] vs.MNo-message = 24%, 95% CI [22%, 26%],
t (1202.59) = 5.47, Cohen’s D = 0.32, r = .16, p< .01. Here, the 7-percentage point absolute
increase in vaccination intentions represents a 30% relative increase, more than twice the effect
size found in the same analysis among all participants. Among these historical non-vaccina-
tors, the identifiable victim messages also marginally increased vaccination intentions com-
pared to the general message,MIdentifiable = 32%, 95% CI [30%, 34%] vs.MGeneral = 29%, 95%
CI [27%, 32%], t (1195.81) = 1.84, Cohen’s D = 0.11, r = .05, p = .07. Vaccination intention did
not differ between the young and old victim conditions among these participants, p> .80.
Country, age, and gender
The effect of message on sympathy, prosocial motivation, and vaccination intentions described
above generally held true same in the analyses of covariance (ANOCOVA), where we con-
trolled for age, gender, country, and interaction between country and message (assessing
Fig 3. Mean Vaccination Intentions across Condition and Past Year Vaccination Status. Error Bars: ± 2SEs
(95% CI).
doi:10.1371/journal.pone.0159780.g003
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cross-country variations in the effect of message). In the interest of space, detailed analyses on
cross-country variations are reported in S2 Supporting Information. Briefly, the effect of mes-
sage varied across countries only for sympathy, but not on prosocial motives or vaccination
intentions. Females and older participants in general showed greater sympathy, prosocial
motives, and vaccination intentions, with a few exceptions. One interesting result was that par-
ticipants living in countries with greater population aging demonstrated a greater gap in sym-
pathy towards the young vs. old victim.
Mediational analyses on vaccination intentions
We have established that the messages eliciting prosocial motives did increase intentions to
vaccinate against flu, especially among those who lacked a recent history of doing so, and more
so if the messages involved an identifiable victim. As the central idea in the current study was
to test prosocial motives in flu vaccination, we tested whether prosocial motivation was indeed
a mediator in these observed effects.
First, we performed a mediational analysis including all participants who had a response to
the vaccination intention question (n = 3518). The predictor was the contrast between the
three message conditions and no message condition, the outcome was vaccination intention,
and the mediator was prosocial motive, as assessed by likelihood to donate to an unrelated
cause. Based on the PROCESS Macro developed for SPSS by Hayes [32], and using a bias-cor-
rected bootstrapping method with 5000 resampling, the indirect effect was significant,
B = 0.018, 95% CI [0.010, 0.027] (Fig 4). Thus, compared to the no-message condition, a net
increase of 1.8-percentage points in vaccination intentions in the message conditions was
attributable to elevated prosociality. Note that the message conditions lead to a 6-percentage
increase in vaccination intentions compared to the no message condition. Thus, about one
third of this increase was due to the meditational effect of prosocial motives.
We then focused on the 2530 participants who had not vaccinated in the past year, where
the effect of message on vaccination intentions was larger. In a similar meditational analysis we
found a significant indirect effect of prosocial motives on the desire to be vaccinated
(B = 0.020, 95% CI [0.009, 0.030], κ2 = .031, 95% CI [0.014, 0.046]). This result indicates that
among those who did not vaccinate in the past year, a net increase of 2 percentage points in
Fig 4. Mediational Model for the effect of message on vaccination intention among all participants,
mediated by prosocial motives. This mediation was based on the bootstrapping method for calculating indirect
effect developed by Hayes[32]. Participants included anyone with a valid response on vaccination intention
(n = 3581). Analysis was performed in SPSS using the PROCESSmacro developed by Hayes [32], with 5000
resampling to compute the Bias Corrected boot strapped 95%Confidence Intervals (BCa CI). Total effect of
message on vaccination intention was significant, B = 0.056, BCa 95%CI [0.029, 0.083], p = .0001.
doi:10.1371/journal.pone.0159780.g004
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vaccination intentions (out of a total of 7 percentage point increase) was attributable to ele-
vated prosociality.
We did not test sympathy as a potential mediator for the effect of message on vaccination
intention, because the sympathy question was directed towards flu victims described in the
messages, and therefore, was not measured in the no-message condition.
Discussion
The results on sympathy confirmed that an identifiable victim in messages elicits increased
sympathy, and that people value younger lives more than older lives [29–31]. However, greater
sympathy towards younger victim did not translate into greater prosocial motivation. We did
find that highlighting the benefit of vaccination to others, as well as using an identifiable victim
in the message, can increase motivation to help others, even when the victims highlighted are
not the target of helping.
As a focus of this paper, the findings concerning vaccination intentions confirmed the
hypothesis that highlighting flu victim increased intentions to vaccinate, especially among peo-
ple who had not vaccinated the previous year. Among these historical non-vaccinators, reading
any of the three messages about victims who suffered from the flu due to others’ failure to vac-
cinate increased their vaccination intention from 24% to 31%, an absolute increase of 7 per-
centage points and relative increase of over 30%. Among this group of participants, there was
also a marginally significant effect of identifiable victim on the intention to vaccinate. These
effects were diluted when the analysis included participants who had vaccinated in the previous
year (who were already highly motivated to vaccinate), but the effect of presenting a message
(versus not) remained significant: When all participants are considered, reading any of the
three messages increased vaccination intentions from 38% to 44%, a 15% relative increase. This
might seem to be a small effect, but as a comparison, a recent randomized trial that delivered
five weekly text-messages regarding flu vaccination to participants increased vaccination rate
from 23% to 27%, an absolute increase of 4 percentage points [33]. Admittedly, the methods of
these two studies are very different. However, the fact that their effect sizes fall into similar
range highlights prosocial messaging as a potentially effective and viable strategy to promote
flu vaccination, especially among people who are historical non-vaccinators.
The mediation analysis showed that prosocial motivation plays a causal role in flu vaccina-
tion, and that roughly one third of the effect of message on vaccination intentions occurred
due to the elevated prosocial motives. Thus, the current research demonstrated prosociality as
a causal factor in flu vaccination, again pointing to the potential of harnessing prosociality in
flu vaccination programs or public health campaigns.
What might be the mechanisms through which this type of messaging worked to increase
prosociality? As mentioned in the introduction, we designed these messages with the intention
to heighten personal responsibility as well as sympathy. Because sympathy was not measured
in the no-message condition in the current study, we could not test how sympathy changed in
response to our messages versus no message. However, supporting past research on the role of
empathetic emotion in prosocial behavior [34], we did find sympathy to be a significant media-
tor in the effect of identified vs. non-identified victims on prosociality (Fig 2). We did not mea-
sure personal responsibility in the current study, as we speculate such a measure may create
demand effect, where participants would feel a greater sense of personal responsibility because
we asked, and indicate greater likelihood to vaccinate than they otherwise would.
Another possible mechanism in how the messages elicited prosocial motives may be mortal-
ity salience, as all our messages mentioned death. Terror Management Theory posits that mor-
tality salience promotes behaviors consistent with cultural standards, and where such
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standards include prosociality, mortality salience can increase donation [35]. This latter mech-
anism may be outside of the initial intention of the current study, but may play a role in how
the victim-focused messaging leads to prosocial acts. Future research can explore these mecha-
nisms in prosocial messaging about flu vaccination.
The current study is the first to evaluate the use of an identifiable victim as a messaging
approach to elicit prosocial behavior directed towards something other than the victim. In con-
trast, previous research on the identifiable victim effect has focused on prosociality towards the
victim only [23–26]. Even though identifiable victim only led to a marginally significant
increase in vaccination intentions in the current study, it significantly increased prosocial
motives in general, measured by the likelihood to donate towards an unrelated illness. Future
studies can explore the domains in which the identifiable victim effect can be harnessed to pro-
mote prosocial behavior.
One potential limitation of the study is the lack of an information-only condition that does
not elicit prosociality. However, to accurately explain the full effect of vaccination, one must
explain herd immunity and thus the benefit of vaccination to others, or importantly, the reduc-
tion of risk to others. And this might elicit prosociality. A control condition, therefore, could
either provide no information, or provide information on the self-interest benefit of flu vaccina-
tion only and ignore herd immunity. Future research could take the latter approach, which
would serve as a test for the relative efficacy of self-interest vs. prosociality oriented messages.
Given that the goal of the current research was to verify the causal role of prosociality in flu vac-
cination, not to compare the relative efficacy of prosocial versus self-interest messages, we took
the former approach and used the no-message condition as control. And the findings in the
meditational analysis described in the end of the results section showed that prosociality indeed
played play a causal role, accounting for roughly one third of the messaging effect on vaccina-
tion intentions when comparing the three message conditions to the no-message condition.
Another limitation is the use of vaccination intention instead of vaccination behavior as the
outcome variable. We did collect follow-up data on flu vaccination behavior in 6 out of the 8
countries, with a response rate of 57%. According to these data, there was no difference in vac-
cination rate across conditions in these limited data. This lack of effect is not too surprising
given the long lag between receiving the message and the actual time in vaccination decisions,
and the results may subject to selection bias in responding. Future research should further
explore the effectiveness of prosocial messages on behavior at doctors’ offices or pharmacies,
where people’s vaccination decisions can be made shortly after exposure to the message.
In summary, the current research provides new insights on the causal role of prosocial
motives in vaccination decisions, and suggests that messages intended to elicit prosocial
motives may be a useful tool to promote flu vaccination. Importantly, prosocial messaging can
be easily incorporated into flu vaccination interventions that have proved to be highly effective,
such as provider reminder messages [36] or default vaccination appointments [37] to further
motivate vaccination, where the implementation of adding prosocial messages will incur little
cost, but may lead to tangible increase in vaccine coverage.
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